C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Diabetologia

• Publication date

  2001-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s001250100570PMID 11508275
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nerve ischaemia in diabetic rats: time-course of development, effect of insulin treatment plus comparison of streptozotocin and BB models

  2004cited by this paper
• C-peptide attenuates protein tyrosine phosphatase activity and enhances glycogen synthesis in L6 myoblasts.

  2001cited by this paper
• Beneficial effects of C‐peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus

  2000cited by this paper
• Role of C-peptide in human physiology.

  2000cited by this paper
• Insulin receptor in rat peripheral nerve: its localization and alternatively spliced isoforms

  2000cited by this paper
• Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy.

  2000cited by this paper
• A comparison of diabetic polyneuropathy in Type II diabetic BBZDR/Wor rats and in Type I diabetic BB/Wor rats

  2000cited by this paper
• Specific binding of proinsulin C-peptide to human cell membranes.

  1999cited by this paper
• Experimental diabetic neuropathy: an update

  1999cited by this paper
• Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels.

  1999cited by this paper
• Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort.

  1999cited by this paper
• Identification of a novel contactin‐associated transmembrane receptor with multiple domains implicated in protein–protein interactions

  1997cited by this paper
• The Axonal Membrane Protein Caspr, a Homologue of Neurexin IV, Is a Component of the Septate-like Paranodal Junctions That Assemble during Myelination

  1997cited by this paper
• Prevention of vascular and neural dysfunction in diabetic rats by C-peptide.

  1997cited by this paper
• C-peptide stimulates rat renal tubular Na+, K+-ATPase activity in synergism with neuropeptide Y

  1996cited by this paper
• Nodal Na(+)-channel displacement is associated with nerve-conduction slowing in the chronically diabetic BB/W rat: prevention by aldose reductase inhibition.

  1996cited by this paper
• C-peptide improves autonomic nerve function in IDDM patients

  1996cited by this paper
• An orderly development of paranodal axoglial junctions and bracelets of Nageotte in the rat sural nerve.

  1996cited by this paper
• Nerve fiber regeneration following axotomy in the diabetic biobreeding Worcester rat: the effect of ARI treatment.

  1996cited by this paper
• Type I Insulin-like Growth Factor Receptor Activation Regulates Apoptotic Proteins*

  1996cited by this paper
• Primary preventive and secondary interventionary effects of acetyl-L-carnitine on diabetic neuropathy in the bio-breeding Worcester rat.

  1996cited by this paper
• Insulin‐like growth factors protect against diabetic neuropathy: Effects on sensory nerve regeneration in rats

  1995cited by this paper
• AnkyrinG. A new ankyrin gene with neural-specific isoforms localized at the axonal initial segment and node of Ranvier.

  1995cited by this paper
• The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat.

  1994cited by this paper
• Aldose reductase gene expression and osmotic dysregulation in cultured human retinal pigment epithelial cells.

  1993cited by this paper
• Aldose reductase inhibitors: an approach to the treatment of diabetic nerve damage.

  1993cited by this paper
• Lesion-induced increase in nerve growth factor mRNA is mediated by c-fos.

  1990cited by this paper
• Influence of nerve growth factor on neurofilament gene expression in mature primary sensory neurons

  1990cited by this paper
• Reduced myelinated fiber size correlates with loss of axonal neurofilaments in peripheral nerve of chronically streptozotocin diabetic rats.

  1990cited by this paper
• Preventive effect of long-term aldose reductase inhibition (ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic Bio-Breeding rat.

  1990cited by this paper
• Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy.

  1988cited by this paper
• Axo-glial dysjunction. A novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic bio-breeding rat.

  1986cited by this paper
• Reversible diabetic nerve dysfunction: Structural correlates to electrophysiological abnormalities

  1985cited by this paper
• Changes in nodal function in nerve fibres of the spontaneously diabetic BB-Wistar rat: potential clamp analysis.

  1981cited by this paper
• Insulin Biosynthesis: Evidence for a Precursor

  1967cited by this paper

• Impact of Islet Transplantation on Type 1 Diabetes-Related Complication: A Systematic Review

  2025cites this paper
• Identification of Serum Biomarkers for Blast-induced Traumatic Brain Injuries: Low vs. High-intensity Exposure in a Rat Model

  2025cites this paper
• Type 1 diabetes mellitus: the liver’s role, sex-specific outcomes, and advances in disease-modifying therapies - a literature review

  2025cites this paper
• The Role of Microcirculatory Dysfunction During Paclitaxel Treatment as a Critical Co-Factor for the Development of Chemotherapy-Induced Peripheral Neuropathy

  2024cites this paper
• The role of C-peptide in diabetes and its complications: an updated review

  2023influential citation
• Effects of C-Peptide on Dexamethasone-Induced In Vitro and In Vivo Models as a Potential Therapeutic Agent for Muscle Atrophy

  2023cites this paper
• Axonal transport deficits in the pathogenesis of diabetic peripheral neuropathy

  2023cites this paper
• Red blood cells in type 1 diabetes and multiple sclerosis and technologies to measure their emerging roles

  2022cites this paper
• Therapeutic Effects of Insulin-Producing Human Umbilical Cord-Derived Mesenchymal Stem Cells in a Type 1 Diabetes Mouse Model

  2022cites this paper
• Specific Binding of Leptin to Red Blood Cells Delivers a Pancreatic Hormone and Stimulates ATP Release.

  2021cites this paper
• C-Peptide as a Therapy for Type 1 Diabetes Mellitus

  2021cites this paper
• Molecular Mechanisms of Action and Physiological Effects of the Proinsulin C-Peptide (a Systematic Review)

  2021cites this paper
• Biological Activity of c-Peptide in Microvascular Complications of Type 1 Diabetes—Time for Translational Studies or Back to the Basics?

  2020cites this paper
• Newer Treatment Horizons of Diabetic Peripheral Neuropathy: From Bench to Bed Side

  2020cites this paper
• The Association of Fasting C-peptide with Corneal Neuropathy in Patients with Type 2 Diabetes

  2020cites this paper
• A C-peptide complex with albumin and Zn2+ increases measurable GLUT1 levels in membranes of human red blood cells

  2020cites this paper
• [Molecular mechanisms of action and physiological effects of the proinsulin C-peptide (a systematic review)].

  2020cites this paper
• Multiple Cell Signalling Pathways of Human Proinsulin C-Peptide in Vasculopathy Protection

  2020cites this paper
• Carbonated beverage consumption is associated with lower C-peptide in adolescents

  2019cites this paper
• Comparative Effect Of Curcumin Versus Liposomal Curcumin On Systemic Pro-Inflammatory Cytokines Profile, MCP-1 And RANTES In Experimental Diabetes Mellitus

  2019cites this paper
• BIOLOGICAL EFFECTS OF C-PEPTIDE AND PROINSULIN: WE JIBE TOGETHER

  2019cites this paper
• Peptídeo C e mortalidade cardiovascular: revisão sistemática e metanálise

  2018cites this paper
• Ultrafiltration binding analyses of glycated albumin with a 3D-printed syringe attachment

  2018cites this paper
• Antidiabetic and Renoprotective Effects of Acankoreagenin from the Leaves of Acanthopanax Gracilistylus in Streptozotocin-Induced Type I Diabetic Rats

  2018cites this paper
• Methylglyoxal Disrupts Paranodal Axoglial Junctions via Calpain Activation

  2018cites this paper
• The dual effect of C‐peptide on cellular activation and atherosclerosis: Protective or not?

  2018cites this paper
• Can high-dose omega-3 fatty acids and high-dose vitamin D3 (cholecalciferol) prevent type 1 diabetes and sustain preservation of beta-cell function after disease onset?

  2018cites this paper
• Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets

  2018cites this paper
• C-Peptide replacement therapy in type 1 diabetes: are we in the trough of disillusionment?

  2017cites this paper
• &ohgr;-3 polyunsaturated fatty acids ameliorate type 1 diabetes and autoimmunity

  2017cites this paper
• The Effects of Lycopene and Insulin on Histological Changes and the Expression Level of Bcl-2 Family Genes in the Hippocampus of Streptozotocin-Induced Diabetic Rats

  2017cites this paper
• C‐peptide antioxidant adaptive pathways in β cells and diabetes

  2017cites this paper
• Proinsulin C-peptide-mediated signalling and the search for its receptor

  2017influential citation
• METHODS FOR TREATINGERECTLE DYSFUNCTION IN PATIENTS WITH NSULIN-DEPENDENT DABETES

  2017cites this paper
• Alternatives to the Streptozotocin-Diabetic Rodent.

  2016cites this paper
• An animal model of diabetic peripheral neuropathy and the pathophysiology of takotsubo syndrome: A proposal of an experiment.

  2016cites this paper
• Long-Acting C-Peptide and Neuropathy in Type 1 Diabetes: A 12-Month Clinical Trial

  2016cites this paper
• Alteration of Leptin and C-Peptide Status in Homozygous Sickle Cell Anaemia

  2016cites this paper
• Pancreatic secretions and their effect on circulatory and immune cells

  2016cites this paper
• Islet cell transplantation improves nerve conduction velocity in type 1 diabetes compared with intensive medical therapy over six years.

  2016cites this paper
• C-peptide: new findings and therapeutic possibilities.

  2015cites this paper
• Pathological consequences of C-peptide deficiency in insulin-dependent diabetes mellitus.

  2015cites this paper
• A 9-Month Toxicity and Toxicokinetic Assessment of Subcutaneous Pegylated Human C-peptide (CBX129801) in Cynomolgus Monkeys

  2015cites this paper
• C-peptide ameliorates renal injury in type 2 diabetic rats through protein kinase A-mediated inhibition of fibronectin synthesis.

  2015cites this paper
• Mechanisms of distal axonal degeneration in peripheral neuropathies.

  2015cites this paper
• C-peptide: a new potential in the therapy of microvascular complications of Type 1 diabetes?

  2015cites this paper
• Role of C-Peptide in Development of Diabetic Neuropathy [DN] Animal Model

  2014cites this paper
• Schwann Cell Development and Pathology

  2014cites this paper
• C-peptide replacement therapy as an emerging strategy for preventing diabetic vasculopathy.

  2014cites this paper
• Autocrine C‐peptide mechanism underlying INS1 beta cell adaptation to oxidative stress

  2014cites this paper
• Physiological effects and therapeutic potential of proinsulin C-peptide.

  2014cites this paper
• Mechanisms of diabetic neuropathy: axon dysfunction.

  2014cites this paper
• Towards A Possible Therapy for Diabetes Complications

  2014cites this paper
• Pathogenesis of Diabetic Neuropathy from the Point of View of Schwann Cell Abnormalities

  2014cites this paper
• Foreword

  2013cites this paper
• Doves, Diplomats, and Diabetes

  2013cites this paper
• Diabetes Associated Cognitive Decline, is there a Role for Exercise?

  2013cites this paper
• Novel therapeutic approach to microvascular complications of type 1 diabetes

  2013cites this paper
• C-Peptid

  2013cites this paper
• Effects of C-Peptide and / or Insulin Administration on Motor Nerve Conduction Velocity in Diabetic Rats

  2013cites this paper
• C-Peptide and Diabetic Neuropathy in Patients with Type 1 Diabetes

  2012cites this paper
• [Pleiotropic action of proinsulin C-peptide].

  2012cites this paper
• Proinsulin C-Peptide Inhibits Lipolysis in Diabetic Rat Adipose Tissue Through Phosphodiestrase-3B Enzyme

  2012cites this paper
• The Clinical Potential of C-Peptide Replacement in Type 1 Diabetes

  2012cites this paper
• Protective effects of combined therapy of gliclazide with curcumin in experimental diabetic neuropathy in rats

  2012cites this paper
• Coenzyme Q10 prevents peripheral neuropathy and attenuates neuron loss in the db−/db− mouse, a type 2 diabetes model

  2012cites this paper
• Of Soldiers and Diplomats

  2012cites this paper
• Is NO-eNOS a Target for C-Peptide Action and Its Protective Effects on Diabetic Nephropathy?

  2012cites this paper
• Caractéristiques immuno-analytiques du peptide-C

  2012cites this paper
• The Mechanisms Underlying the Effects of C-Peptide on Type 1 Diabetic Neuropathy

  2012cites this paper
• How the immunoassay transformed C-peptide from a duckling into a swan

  2012cites this paper
• C-Peptide Increases Na,K-ATPase Expression via PKC- and MAP Kinase-Dependent Activation of Transcription Factor ZEB in Human Renal Tubular Cells

  2011cites this paper
• C‐peptide and long‐term complications of diabetes

  2011cites this paper
• Клинико-экспертная диагностика гастроинтестинальной формы диабетической

  2011cites this paper
• Biological Significances, Diagnostic Values and Therapeutic Approach of Proinsulin Connecting Peptide

  2011cites this paper
• A neuropathia diabetica patomechanizmusa: az oki kezelés elméleti háttere Pathomechanism of diabetic neuropathy:

  2010cites this paper
• Proinsulin C‐peptide prevents type‐1 diabetes‐induced decrease of renal Na+‐K+‐ATPase α1‐subunit in rats

  2010cites this paper
• A neuropathia diabetica patomechanizmusa: az oki kezelés elméleti háttere

  2010cites this paper
• [Pathomechanism of diabetic neuropathy: background of the pathogenesis-oriented therapy].

  2010cites this paper
• A neuropathia diabetica patomechanizmusa: az oki kezelés elméleti háttere

  2010cites this paper
• A neuropathia diabetica patomechanizmusa: az oki kezelés elméleti háttere Pathomechanism of diabetic neuropathy:

  2010cites this paper
• New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}.

  2010cites this paper
• The importance of residual endogenous beta-cell preservation in type 1 diabetes

  2009cites this paper
• Cellular and physiological effects of C-peptide.

  2009cites this paper
• Dynamic Changes of Neuroskeletal Proteins in DRGs Underlie Impaired Axonal Maturation and Progressive Axonal Degeneration in Type 1 Diabetes

  2009cites this paper
• [C-peptide: a by-product of insulin biosynthesis or an active peptide hormone?].

  2009cites this paper
• Pathobiology of Diabetic Encephalopathy in Animal Models

  2009cites this paper
• Studies of gastric motility in health and diabetes.

  2009cites this paper
• Review: The importance of residual endogenous beta-cell preservation in type 1 diabetes

  2009cites this paper
• The beneficial effects of C-Peptide on diabetic polyneuropathy.

  2009cites this paper
• Peptide C : un coproduit de la biosynthèse de l ’ insuline ou une hormone peptidique active ?

  2008cites this paper
• C-Peptide and Its C-Terminal Fragments Improve Erythrocyte Deformability in Type 1 Diabetes Patients

  2008cites this paper
• Effect of C-Peptide on Diabetic Neuropathy in Patients with Type 1 Diabetes

  2008cites this paper
• Is C-peptide replacement the missing link for successful treatment of neurological complications in type 1 diabetes?

  2008cites this paper
• Growth factors as therapeutics for diabetic neuropathy.

  2008cites this paper
• Diabetic neuropathy: mechanisms to management.

  2008cites this paper
• The heterogeneity of diabetic neuropathy.

  2008cites this paper
• C-Peptide Effects on Renal Physiology and Diabetes

  2008cites this paper
• The Effects of C-peptide on Type 1 Diabetic Polyneuropathies and Encephalopathy in the BB/Wor-rat

  2008cites this paper
• Metabolic-Functional-Structural Correlations in Somatic Neuropathies in the Spontaneously Type 1 and Type 2 Diabetic BB-Rats

  2007cites this paper